Guideline thresholds & controversial drugs
Statins, blood-pressure and prediabetes thresholds, and industry ties of guideline panels.
Don't stop, replace, or delay any treatment without talking to your doctor.
Guideline thresholds & controversial drugs · 2019-03-07 · Charles Piller, Science (AAAS), March 7, 2019
ADA "ratcheted down its prediabetes A1c threshold from 6.1% to 5.7%," creating "about 72 million potential new prediabetes patients in the United States alone." "Seven of the 14 ADA experts got between $41,000 and $6.8 m…
Guideline thresholds & controversial drugs · 2018-05-31 · Kei Miyazaki, MD, PhD, Journal of General and Family Medicine, 2018
"It is a serious intellectual COI that the Chair of the SPRINT trial steering committee was commissioned as chair of the guideline panel." "The new threshold would lead to 46 percent of the U.S. adult population being ca…
Guideline thresholds & controversial drugs · 2013-11-21 · Jeanne Lenzer, The BMJ, November 21, 2013
"The chairman and one of two additional co-chairs ... had ties to the drug industry at the time they were asked to lead the panel. And, in all, eight of the 15 panelists had industry ties." The chair "acknowledged ... th…
Paper Trail Health summarizes published studies, case reports, court filings and journalism for general information. It is not medical, legal or investment advice. Summaries quote the sources; a source's statements are its authors', not findings of this site. Don't stop, replace, or delay treatment without your doctor. Always read the linked original. See
Standards & corrections and
Disclaimer.